Angiotensin-converting enzyme inhibition and AT1 receptor blockade modify the pressure-natriuresis relationship by additive mechanisms in rats with human renin and angiotensinogen genes

Journal of the American Society of Nephrology

Volumn 10, Issue 8, 1999, Pages 1669-1680

  Mervaala, Eero ^a,b   Dehmel, Bastian ^a   Gross, Volkmar ^a   Lippoldt, Andrea ^a   Bohlender, Jürgen ^a   Milia, Anna Franca ^a,c   Ganten, Detlev ^a   Luft, Friedrich C ^a,d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Lab Naz Biotech e Biostructure   (Italy)

^d FRANZ VOLHARD CLINIC   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; BRADYKININ; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; NITRIC OXIDE SYNTHASE; RENIN; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GENE OVEREXPRESSION; HYPERTENSION; MALE; NATRIURESIS; NEPHROSCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM EXCRETION; WATER ABSORPTION;

EID: 0032840293     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v1081669     Document Type: Article

References (34)

1. Bohlender J, Fukamizu A, Lippoldt A, Nomura T, Dietz R, Ménard J, Murakami K, Luft FC, Ganten D: High human renin hypertension in transgenic rats. Hypertension29: 428-434, 1997
2. Dehmel B, Mervaala E, Lippoldt A, Gross V, Bohlender J, Ganten D, Luft FC: Pressure-natriuresis and -diuresis in transgenic rats harboring both human renin and human angiotensinogen genes. J Am Soc Nephrol 9: 2212-2222, 1998
3. Hall JE: Regulation of glomerular filtration rate and sodium excretion by angiotensin II. Fed Proc 45: 1431-1437, 1986
4. Franco M, Paniagua R, Herrea-Acosta J: Renal effects of renin-angiotensin system blockade. Curr Opin Nephrol Hypertens 7: 153-158, 1998
5. Harris PJ, Navar L: Tubular transport responses to angiotensin. Am J Physiol 248: F621-F630, 1985
6. Kline RL, Liu F: Modification of pressure natriuresis by long-term losartan in spontaneously hypertensive rats. Hypertension 24: 467-473, 1994
7. Fenoy FJ, Milicic I, Smith RD, Wong PC, Timmermanns V, Roman RJ: Effects of DuP 753 on renal function of normotensive and spontaneously hypertensive rats. Am J Hypertens 4: 321S-326S, 1991
8. Gross V, Lippoldt A, Yagil C, Yagil Y, Luft FC: Pressure natriuresis in salt-sensitive and salt-resistant Sabra rats. Hypertension 29: 1252-1259, 1997
9. Führ J, Kaczmarczyk J, Krüttgen CD: Eine einfache colorimetrische Methode zur Inulinbestimmung für Nieren-Clearanceuntersuchungen bei Stoffwechselgesunden und Diabetikern. Klin Wochenschr 33: 729-730, 1955
10. Führ J: Clearance-Methoden zur Nierenfunktionsprüfung unter besonderer Berücksichtigung des Total-Clearance-Verfahrens. Ärzt Labor 4: 79-95, 1958
11. Gross V, Lippoldt A, Schneider W, Luft FC: Effect of captopril and AT1-receptor blockade on pressure natriuresis and diuresis in (mRen2)27 transgenic rats. Hypertension 26: 471-479, 1995
12. Gross V, Lippoldt A, Bohlender J, Bader M, Hansson A, Luft FC: Cortical and medullary hemodynamics in deoxycorticosterone acetate-salt hypertensive mice. J Am Soc Nephrol 9: 346-354, 1998
13. Lippoldt A, Gross V, Schneider K, Hansson A, Nadaud S, Schneider W, Bader M, Yagil C, Yagil Y, Luft FC: Nitric oxide synthase and renin-angiotensin system gene expression in salt-sensitive and salt-resistant Sabra rats. Hypertension 30: 409-415, 1997
14. Lippoldt A, Gross V, Bohlender J, Ganten U, Luft FC: Lifelong angiotensin converting enzyme inhibition, pressure natriuresis, and renin-angiotensin system gene expression in transgenic (mRen-2)27 rats. J Am Soc Nephrol 7: 2119-2129, 1996
15. Luft FC, Mervaala E, Muller D, Gross V, Schmidt F, Park J-K, Schmitz C, Lippoldt A, Breu V, Dechend R, Dragun D, Schneider W, Ganten D, Haller H: Hypertension-induced end-organ damage: A new transgenic approach to an old problem [Review]. Hypertension 33: 212-218, 1999
16. Mervaala EM, Muller D, Park J-K, Schmidt F, Breu V, Dragun D, Ganten D, Haller H, Luft FC: Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension. Hypertension 33: 389-395, 1999
17. Van Der Mark J, Kline RL: Altered pressure natriuresis in chronic angiotensin II hypertension in rats. Am J Physiol 266: R739-R748, 1994
18. Wang C-T, Zou L-X, Navar LG: Renal responses to AT1 blockade in angiotensin II-induced hypertensive rats. J Am Soc Nephrol 8: 535-542, 1997
19. Gross V, Roman RJ, Cowley AW Jr: Abnormal pressure natriuresis in transgenic renin gene rats. J Hypertens 12: 1029-1034, 1994
20. Cowley AW: Role of the renal medulla in volume and arterial pressure regulation. Am J Physiol 273: R1-R15, 1997
21. Zusman RM: Renin- and non-renin-mediated antihypertensive actions of converting enzyme inhibitors. Kidney Int 25: 969-983, 1984
22. Largo R, Gomez-Garre D, Liu XH, Alosno J, Blanco J, Plaza JJ, Egido J: Endothelin-1 upregulation in the kidney of uninephrectomized spontaneously hypertensive rats and its modification by the angiotensin-converting enzyme inhibitor quinapril. Hypertension 29: 1178-1185, 1997
23. Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA: Contributions of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 47: 25-49, 1995
24. Willis LR, Ludens JH, Hook JB, Williamson HE: Mechanisms of natriuretic action of bradykinin. Am J Physiol 217: F1-F15, 1969
25. Granger JP, Hall JE: Acute and chronic actions of bradykinin on renal function and arterial pressure. Am J Physiol 248: F87-F92, 1985
26. Carretero OA, Scicli AG: Local hormonal factors (intracrine, autocrine and paracrine) in hypertension. Hypertension 18[Suppl I]: 58-69, 1991
27. Dukacz SAW, Adams MA, Kline RL: The persistent effect of long-term enalapril on pressure natriuresis in spontaneously hypertensive rats. Am J Physiol 273: F104-F112, 1997
28. Harrap SB, Nicolai JA, Doyle AE: Persistent effect on blood pressure and renal haemodynamics following chronic angiotensin converting enzyme inhibition with perindopril. Clin Exp Pharmacol Physiol 13: 735-765, 1986
29. Navar LG, Jirakulsomehok D, Bell PD, Thomas CE, Huang WC: Influence of converting enzyme inhibition on renal hemodynamics and glomerular dynamics in sodium-restricted dogs. Hypertension 4: 58-62, 1982
30. Göransson A, Sjöquist M, Ulfendahl HR: Superficial and juxtamedullary nephron function during converting enzyme inhibition. Am J Physiol 251: F25-F33, 1986
31. Navar LG, Inscho EW, Majid DAS, Imig JD, Harrison-Bernard LM, Mitchell KD: Paracrine regulation of the renal microcirculation. Physiol Rev 76: 425-536, 1996
32. Bohm M, Lee M, Kreutz R, Kim S, Schinke M, Djavidani B, Wagner J, Kaling M, Wienen W, Bader M: Angiotensin II receptor blockade in TGR(mREN2)27: Effects of renin-angiotensin-system gene expression and cardiovascular functions. J Hypertens 13: 891-899, 1995
33. Kelly MP, Kahr O, Aalkjaer C, Cumin F, Samani NJ: Tissue expression of components of the renin-angiotensin system in experimental post-infarction heart failure in rats: Effects of heart failure and angiotensin-converting enzyme inhibitor treatment. Clin Sci 92: 455-465, 1997
34. Sechi LA, Griffin CA, Giacchetti G, Valentin JP, Liorens-Cortes C, Corvol P, Schambelan M: Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat. Hypertension 28: 403-408, 1996